Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial

Autor: Franck Morschhauser, Michel Henry-Amar, Richard W.M. van der Maazen, Francisca Ong, Houchingue Eghbali, Isabelle Gaillard, B. Christian, Max Beijert, Marc André, Pieternella J. Lugtenburg, Jean Gabarre, Josée Audouin, Olivier Boulat, G Tertian, Dominique Bordessoule, Philippe Hélias, Christophe Fermé, Aspasia Stamatoullas, Andrej Vranovsky, José Thomas, Judith M. Roesink, Umberto Tirelli, Daphne de Jong, Krimo Bouabdallah, Marnix L.M. Lybeert, Berthe M.P. Aleman, Hugo Gonzalez, Philippe Quittet, Evert M. Noordijk, Jérôme Jaubert, Theodore Girinsky

Publikováno v: International journal of radiation oncology, biology, physics, 100(5), 1133-1145. Elsevier Inc.
International Journal of Radiation Oncology, Biology, Physics, 100, 5, pp. 1133-1145
Thomas, J, Fermé, C, Noordijk, E M, Morschhauser, F, Girinsky, T, Gaillard, I, Lugtenburg, P J, André, M, Lybeert, M L M, Stamatoullas, A, Beijert, M, Hélias, P, Eghbali, H, Gabarre, J, van der Maazen, R W M, Jaubert, J, Bouabdallah, K, Boulat, O, Roesink, J M, Christian, B, Ong, F, Bordessoule, D, Tertian, G, Gonzalez, H, Vranovsky, A, Quittet, P, Tirelli, U, de Jong, D, Audouin, J, Aleman, B M P & Henry-Amar, M 2018, ' Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors : Results of the EORT-GELA H9-F Intergroup Randomized Trial ', International journal of radiation oncology, biology, physics, vol. 100, no. 5, pp. 1133-1145 . https://doi.org/10.1016/j.ijrobp.2017.10.015
International Journal of Radiation Oncology Biology Physics, 100(5), 1133-1145. Elsevier Inc.
International Journal of Radiation Oncology, Biology, Physics, 100, 1133-1145
International Journal of Radiation: Oncology-Biology-Physics, Vol. 100, p. 1133-1145 (2018)
International Journal of Radiation Oncology Biology Physics, 100(5), 1133-1145. ELSEVIER SCIENCE INC

PURPOSE: While patients with early-stage Hodgkin lymphoma (HL) have an excellent outcome with combined treatment, the radiation therapy (RT) dose and treatment with chemotherapy alone remain questionable. This noninferiority trial evaluates the feasi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333d40ec009294537c3dd25c74fc9ef8
https://doi.org/10.1016/j.ijrobp.2017.10.015

Should Adolescents with Hodgkin Lymphoma Be Treated as Old Children or Young Adults?

Autor: Judith Landman-Parker, Odile Oberlin, Patrice Carde, Christophe Fermé, Berthe M. P. Aleman, Thierry Leblanc, John M. M. Raemaekers, Catherine Sebban, Evert M. Noordijk, Luc-Matthieu Fornecker, Houchingue Eghbali, Josette Brière, Michel Henry-Amar

Publikováno v: SSRN Electronic Journal.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f4a93a29cc8f43ac75a387f03af710b
https://doi.org/10.2139/ssrn.3212333

Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly

Autor: M.A. MacKenzie, Daphne de Jong, Houchingue Eghbali, Gilbert B. Zulian, I. Teodorovic, Catherine Fortpied, Muriel Rainfray, Robrecht de Bock, Muriel Debois, Alain Monnereau, Pierre Soubeyran, Hussein M. Khaled, Joël Ceccaldi

Publikováno v: Journal of Geriatric Oncology. 2:36-44

Objectives Many frail elderly patients with diffuse large B-cell lymphoma (DLBCL) cannot tolerate standard chemotherapy treatment. The objective of this phase II trial was to assess the efficacy of a cautious COP-based (cyclophosphamide, vincristine,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::43cb94ba6b674a886bd9a685f9838e43
https://doi.org/10.1016/j.jgo.2010.08.006

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95

Autor: Noel Milpied, Thierry Lamy, Antoine Thyss, Steven Le Gouill, Jean François Rossi, Virginie Lucas, Eric Deconinck, Bernard Desablens, Audrey Simon, Philippe Casassus, Philippe Colombat, Jean Pierre Vilque, Jérôme Jaubert, Frédéric Maloisel, Michel Peoc'h, Charles Foussard, Olivier Tournilhac, Vincent Delwail, Remy Gressin, Houchingue Eghbali

Publikováno v: British Journal of Haematology. 151:159-166

Peripheral T-Cell lymphomas (PTCL) are relatively rare diseases but appear to be highly aggressive and display worse remission and survival rates than B-cell lymphomas. Despite unsatisfactory results with the cyclophosphamide, doxorubicin, vincristin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::92cea523055b4ae5c65db7ebe645e99b
https://doi.org/10.1111/j.1365-2141.2010.08329.x

High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia

Autor: Karim Maloum, Jérôme Jaubert, Jacques Benichou, Frédéric Maloisel, Brigitte Dreyfus, Marine Divine, Pierre Feugier, Odile Guibon, Olivier Tournilhac, Philippe Travade, Charles Dumontet, Stéphane Leprêtre, Michel Leporrier, Alain Delmer, Houchingue Eghbali, Beatrice Mahe, Bruno Cazin, Xavier Leleu, Bernard Grosbois

Publikováno v: British Journal of Haematology. 143:54-59

A multicentre single-arm study testing the efficacy and toxicity of the oral combination of fludarabine and cyclophosphamide (FC) over 5 d in 75 patients with untreated B cell-chronic lymphocytic leukaemia. Oral FC demonstrated high efficacy with ove

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00e913aee04cac63dae6a730d097815
https://doi.org/10.1111/j.1365-2141.2008.07309.x